These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19758768)

  • 1. About strawberry, crab claws, and the Sir James Black's invention. Hypothesis: can we battle keloids with propranolol?
    de Mesquita CJ
    Med Hypotheses; 2010 Feb; 74(2):353-9. PubMed ID: 19758768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
    Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
    Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol treatment for infantile hemangiomas.
    Buckmiller LM
    Curr Opin Otolaryngol Head Neck Surg; 2009 Dec; 17(6):458-9. PubMed ID: 19858718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of apoptosis-related genes in keloid tissues.
    Sayah DN; Soo C; Shaw WW; Watson J; Messadi D; Longaker MT; Zhang X; Ting K
    J Surg Res; 1999 Dec; 87(2):209-16. PubMed ID: 10600351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen consumption of keloids and hypertrophic scars.
    Ichioka S; Ando T; Shibata M; Sekiya N; Nakatsuka T
    Ann Plast Surg; 2008 Feb; 60(2):194-7. PubMed ID: 18216515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemangiomas: new insight and medical treatment.
    Neri I; Balestri R; Patrizi A
    Dermatol Ther; 2012; 25(4):322-34. PubMed ID: 22950559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern treatment of keloids].
    Djoković R; Karadaglić Dj
    Srp Arh Celok Lek; 1997; 125(5-6):176-80. PubMed ID: 9265241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
    Slemp AE; Kirschner RE
    Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microvessels in hypertrophic scars, keloids and related lesions: a review.
    Kischer CW
    J Submicrosc Cytol Pathol; 1992 Apr; 24(2):281-96. PubMed ID: 1600518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of keloids and hypertrophic scars using bleom.
    Aggarwal H; Saxena A; Lubana PS; Mathur RK; Jain DK
    J Cosmet Dermatol; 2008 Mar; 7(1):43-9. PubMed ID: 18254811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of keratins during abnormal wound healing in human skin.
    Prathiba V; Rao KS; Gupta PD
    Cytobios; 2001; 104(405):43-51. PubMed ID: 11219730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of keloids and hypertrophic scars.
    Juckett G; Hartman-Adams H
    Am Fam Physician; 2009 Aug; 80(3):253-60. PubMed ID: 19621835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic scars and keloids.
    Haverstock BD
    Clin Podiatr Med Surg; 2001 Jan; 18(1):147-59. PubMed ID: 11344975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars.
    Naeini FF; Najafian J; Ahmadpour K
    Dermatol Surg; 2006 Aug; 32(8):1023-9; discussion 1029-30. PubMed ID: 16918564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of keloid and hypertrophic scar; correlation of the water proton relaxation times with the duration of the scar.
    Babu M; Bai RP; Suguna L; Ramachandran K; Ramakrishnan KM
    Physiol Chem Phys Med NMR; 1993; 25(2):113-20. PubMed ID: 8397424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of keloid with intralesional bleomycin].
    Bodokh I; Brun P
    Ann Dermatol Venereol; 1996; 123(12):791-4. PubMed ID: 9636763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study.
    Saray Y; Güleç AT
    Int J Dermatol; 2005 Sep; 44(9):777-84. PubMed ID: 16135153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
    Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
    Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.